Clinical Trials Browser

Completed × Sulindac × Clear all

NCT04542135 2025-06-03

Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT01515137 2023-03-28

Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Phase 2 Completed

114 enrolled 11 charts

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

NCT01483144 2021-06-08

Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

Phase 3 Completed

171 enrolled 13 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT00299195 2020-11-19

A Randomized Study of Sulindac in Oral Premalignant Lesions

Phase NA Completed

63 enrolled 10 charts

Coproporphyria, Leukoplakia, Oral, Neoplasms

NCT00068419 2020-02-19

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

Phase 2 Completed

70 enrolled 11 charts

Desmoid Tumors

NCT00841204 2017-12-26

Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma

Phase 2 Completed

50 enrolled 15 charts

Precancerous Conditions

NCT00335504 2017-02-15

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Phase 2 Completed

85 enrolled 10 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

NCT01187901 2016-06-17

FAPEST

Phase 2 Completed

92 enrolled 11 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT00343629 2015-04-28

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

Phase NA Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00118365 2015-01-22

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

Phase 3 Completed

375 enrolled 27 charts

Precancerous Conditions

NCT00755976 2014-12-31

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma

NCT00368927 2014-05-23

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

Phase 2 Completed

61 enrolled 11 charts

Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Precancerous Conditions, Tobacco Use Disorder

NCT00039520 2014-05-06

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00245024 2013-05-03

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

Phase 1 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating